R&D expenses of Moderna 2016-2022

Published by
Matej Mikulic,
Aug 29, 2023
The statistic illustrates the research and development expenses of Moderna Inc. between 2016 and 2022. Moderna spent around 3.3 billion U.S. dollars on R&D in 2022, significantly more than in previous years. The company became widely known for being one of two companies worldwide which had their COVID-19 vaccine approved already in late 2020.

Research and development expenses of Moderna Inc. from 2016 to 2022 (in million U.S. dollars)

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2023

Region

Worldwide

Survey time period

2016 to 2022

Open this statistic in...
Spanish
Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Moderna Inc. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Moderna Inc.

Market overview

6

Key figures

5

Competitors

4

Focus: COVID-19

8

Further related statistics

16

Further Content: You might find this interesting as well

Statistics

Topics

ModernaGlobal pharmaceutical industryPfizerBioNTechVaccinations in the U.S.
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu